Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

54 trials with published results (10%)

Research Maturity

272 completed trials (50% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.9%

32 terminated out of 541 trials

Success Rate

89.5%

+2.9% vs benchmark

Late-Stage Pipeline

20%

106 trials in Phase 3/4

Results Transparency

20%

54 of 272 completed with results

Key Signals

54 with results89% success32 terminated

Data Visualizations

Phase Distribution

368Total
Not Applicable (171)
Early P 1 (3)
P 1 (29)
P 2 (59)
P 3 (43)
P 4 (63)

Trial Status

Completed272
Recruiting85
Unknown83
Terminated32
Not Yet Recruiting22
Withdrawn18

Trial Success Rate

89.5%

Benchmark: 86.5%

Based on 272 completed trials

Clinical Trials (541)

Showing 20 of 20 trials
NCT06458998Not ApplicableEnrolling By Invitation

Getting To Implementation: Improving Cancer Screening for Veterans

NCT07046429Not ApplicableRecruiting

Affect of Melatonin on Sleep and Cognition in Cirrhosis

NCT05045482Phase 1Recruiting

Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease

NCT07417163Not ApplicableCompletedPrimary

LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia

NCT06327308Phase 1RecruitingPrimary

Evaluation of Cirrhotic Cardiomyopathy by Cardiac MRI in Patients Waiting for Liver Transplant.

NCT02968810Phase 2Active Not RecruitingPrimary

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

NCT07029243Not ApplicableRecruitingPrimary

Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis

NCT05260268Not ApplicableActive Not Recruiting

Technology Enabled Strategies to Promote Treatment Adherence in Liver Transplant

NCT05548452Phase 1Recruiting

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

NCT07703540CompletedPrimary

Inferior Vena Cava Pressure as Alternative to Hepatic Venous Pressure for EUS-guided Portal Pressure Gradient Measurement

NCT06062108CompletedPrimary

Prevalence of Pain in Hospitalized Cirrhotic Patients

NCT03849235Not ApplicableCompletedPrimary

A Pathophysiological Study of the Postprandial Human Liver (PLS)

NCT04365868Phase 2Terminated

Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

NCT04490330Terminated

Screening for Alcohol-related Cognitive Impairments in Cirrhotic Patients

NCT07042919Phase 1Recruiting

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

NCT07668778Phase 3Not Yet RecruitingPrimary

Evaluation of a Modified Bowel Preparation Regimen in Cirrhotic Patients Undergoing Colonoscopy

NCT07554183Not ApplicableNot Yet RecruitingPrimary

4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis

NCT02626312Phase 1Terminated

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

NCT05486572Not ApplicableRecruiting

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

NCT07647978Not Yet RecruitingPrimary

Development of a Predictive Score for the Risk of Infection in the Immediate Post-liver-transplant Period

Scroll to load more

Research Network

Activity Timeline